Use of a VEGF antagonist to treat angiogenic eye disorders | Patent Number 10130681

US 10130681 B2
Application Number15471506
Publication NumberUS 20170202911 A1
Pendency1 year, 7 months, 27 days
Filled DateMar 28, 2017
Priority DateJan 13, 2011
Publication DateJul 20, 2017
Expiration DateJan 12, 2031
Inventor/ApplicantsGeorge D. Yancopoulos
ExaminesLOCKARD, JON MCCLELLAND
Art Unit1647
Technology Center1600
Assignments
Regeneron Pharmaceuticals
Current
Regeneron Pharmaceuticals
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.